Revised roles of ISL1 in a hES cell-based model of human heart chamber specification
Year: 2018
Type: article
Abstract: The transcription factor ISL1 is thought to be key for conveying the multipotent and proliferative properties of cardiac precursor cells. Here, we investigate its function upon cardiac induction of human embryonic stem cells. We find that ISL1 does not stabilize the transient cardiac precursor cell state but rather serves to accelerate cardiomyocyte differentiation. Conversely, ISL1 depletion delays cardiac differentiation and respecifies nascent cardiomyocytes from a ventricular to an atrial identity. Mechanistic analyses integrate this unrecognized anti-atrial function of ISL1 with known and newly identified atrial inducers. In this revised view, ISL1 is antagonized by retinoic acid signaling via a novel player, MEIS2. Conversely, ISL1 competes with the retinoic acid pathway for prospective cardiomyocyte fate, which converges on the atrial specifier NR2F1. This study reveals a core regulatory network putatively controlling human heart chamber formation and also bears implications for the subtype-specific production of human cardiomyocytes with enhanced functional properties.
Source: eLife
DOI: 10.7554/elife.31706
Institutions: Max Planck Society, Max Planck Institute for Molecular Biomedicine, Chemical Genomics Centre, University of Münster, Brigham and Women's Hospital, Harvard University, Ikerbasque, Biogipuzkoa Health Research Institute, Amsterdam UMC Location University of Amsterdam, University of Amsterdam, Maastricht University
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,500
OpenAlex ID: W2782664696
